<DOC>
	<DOCNO>NCT00767572</DOCNO>
	<brief_summary>Coarctation aorta ( CoA ) account approximately 8 % congenital heart problem . Patients CoA well know increase rate early heart disease , high blood pressure , heart failure stroke . Abnormal arterial function ( dilation constriction blood vessel ) observe patient likely contributes increase risk cardiovascular problem . However , therapy target improve arterial function investigate population . Statin therapy ( cholesterol medicine like Lipitor ) study subgroups patient abnormal arterial function show benefit improve arterial function reduce risk cardiovascular problem . The investigator hypothesize patient CoA abnormal arterial function lead increase cardiovascular risk . We hypothesize statin therapy may improve problem . We plan compile complete database information regard patient cardiovascular health propose examine effect atorvastatin ( Lipitor ) arterial function measure change arm arterial function test .</brief_summary>
	<brief_title>Statins Endothelial Function Patients With Coarctation Aorta</brief_title>
	<detailed_description>The study design randomize double-blind cross clinical trial . Patients meet inclusion criterion exclusion criterion enrol . They undergo baseline cardiovascular assessment include echocardiography , magnetic resonance image magnetic resonance angiography ( MRI/MRA ) , serum blood sample , brachial artery reactivity testing , carotid intimal medium thickness test . Once complete baseline testing , randomize either atorvastatin 80mg placebo . They complete 12 week therapy return end 12 week repeat brachial artery study serum study . There four week washout period take medication . They return follow visit end four week period repeat baseline brachial artery test serum study . They assign opposite agent previously ( originally placebo switch atorvastatin vice versa ) . They complete another 12 week therapy return end final brachial artery study blood testing .</detailed_description>
	<mesh_term>Aortic Coarctation</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>patient age 18 year repair coarctation aorta ( CoA ) willing participate portion study include follow , blood draw , urine sample , echocardiogram , MRI , brachial artery flowmediated dilatation ( FMD ) testing , Carotid Intima Media Thickness ( CIMT ) test statin administration . patient pregnant , nursing , plan become pregnant subsequent year current smoker patient document coronary artery disease ( CAD ) , systemic inflammatory disorder systemic lupus erythematosis rheumatoid arthritis patient already statin therapy previous adverse effect statin therapy patient hepatic transaminase &gt; 2X upper limit normal patient creatinine clearance &lt; 60mg/dL patient implanted device pacemaker defibrillator preclude MRI test patient low blood pressure baseline ( &lt; 90/50 ) patient unwilling unable comply aforementioned portion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Coarctation aorta</keyword>
	<keyword>cross design</keyword>
	<keyword>atorvastatin</keyword>
	<keyword>endothelial function</keyword>
</DOC>